David Kirn

faculty photo

Adjunct Professor, Department of Bioengineering
CEO and Co-Founder, 4D Molecular Therapeutics



davidhkirn@gmail.com

For more information, see: http://www.linkedin.com/in/davidkirnmd

Research Interests

Find more information at http://www.4dmt.com.

Education

Certificate of Business Excellence, Haas Business School
University of California, Berkeley
Fellowship, Medical Oncology
University of California, San Francisco

Clinical Research & Biostatistics Program Scholar
University of California, San Francisco

Internal Medicine Residency, Brigham and Women’s Hospital
Harvard Medical School

Doctor of Medicine (MD), Medicine
University of California, San Francisco

BA, Physiology, Physical Anthropology
University of California, Berkeley

Professional Experience

Adjunct Professor
UC Berkeley, Department of Bioengineering

Co-Founder & CEO, co-Chairman
4D Molecular Therapeutics

J & J Entrepreneur Innovator
Johnson & Johnson

SVP, Global Clinical R&D, Hematology/Oncology
Celgene

Founder, CEO & President of R&D
Jennerex Biotherapeutics

Professor, Visiting (Adjunct)
University of Oxford Medical School, Dept of Clinical Pharmacology

Founder & President
Kirn Oncology Biotherapeutics Consulting

Associate Professor (Senior Lecturer)
Imperial College London, Cancer Biotherapeutics & Oncolytic Virotherapy R&D Program

Assistant Professor (Adjunct)
UCSF, Dept Medicine, Div Medical Oncology

Vice President, R&D
Onyx Pharmaceuticals